GENERA
Live / Registered — International registration cancelled — extension of protection cancelled (as of 28 Oct 2015)
What this means for you
Registered since 10 Feb 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79140678
- Registration number
- 4683173
- Mark type
- Stylized text
- Filed
- 26 Nov 2013
- Published for opposition
- 25 Nov 2014
- Registered
- 10 Feb 2015
- Attorney of record
- Stewart J. Bellus & Sara M. Dorchak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in gene therapy for the treatment of tumors, haematological malignancies and genetic diseases
- Class 010 — Medical apparatus: Medical devices for cell manipulation, namely, closed systems comprised of sterile plastics and tubes and mechanical parts consisting of peristaltic pumps that allow cell incubation, cell washing, cell expansion and cell concentration
- Class 042 — Scientific and technological services: Medical research and consulting in the field of cell and gene therapy, molecular medicine, cancer treatment, AIDS treatment, genetic disorders treatment and angiogenic disorders treatment; genetic engineering laboratory and biomedical laboratory
Owner
- Molmed S.p.A., IT
- Molmed S.p.A., IT
- Molmed S.p.A., IT
Prosecution history
- 26 May 2016 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 26 May 2016 — DEATH OF INTERNATIONAL REGISTRATION
- 11 Jul 2015 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 11 Jun 2015 — FINAL DISPOSITION NOTICE SENT TO IB
- 11 Jun 2015 — FINAL DISPOSITION PROCESSED
- 10 May 2015 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 10 Feb 2015 — REGISTERED-PRINCIPAL REGISTER
- 25 Nov 2014 — PUBLISHED FOR OPPOSITION
- 05 Nov 2014 — NOTICE OF PUBLICATION
- 18 Oct 2014 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 17 Oct 2014 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Sept 2014 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Sept 2014 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Sept 2014 — ASSIGNED TO LIE
- 11 Sept 2014 — TEAS RESPONSE TO OFFICE ACTION RECEIVED